Dan Dearborn - 12 Dec 2025 Form 4 Insider Report for TuHURA Biosciences, Inc./NV (HURA)

Role
Chief Financial Officer
Signature
/s/ Dan Dearborn
Issuer symbol
HURA
Transactions as of
12 Dec 2025
Net transactions value
$0
Form type
4
Filing time
17 Dec 2025, 06:37:42 UTC
Previous filing
14 Nov 2024
Next filing
08 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dearborn Dan Chief Financial Officer 10500 UNIVERSITY CENTER DRIVE, SUITE 110, TAMPA /s/ Dan Dearborn 17 Dec 2025 0001975443

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HURA Options (Right to Buy) Award $0 +1,531,367 $0.000000 1,531,367 12 Dec 2025 Common Stock 1,531,367 $1.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the stock options become exercisable on the first, second, and third anniversary of December 12, 2025.